RXRX
NASDAQ · Biotechnology
Recursion Pharmaceuticals-A
$3.52
+0.02 (+0.57%)
Analyst Consensus
Buy
13
Analysts
Moderate
Coverage
Price Target
Analyst Price Target
+721.0% upside
Low Target
$21.05
Average Target
$28.90
High Target
$39.88
Current Price
$3.52
Current
$3.52
$3.52
Target
$28.90
$28.90
$21.05
$28.90 avg
$39.88
Scenario Analysis
Bear Case
$21.05
498.0%
Low target
Base Case
$28.90
+721.0%
Avg target
Bull Case
$39.88
+1,033.0%
High target
Risk/Reward
2.1x
Favorable
Price in Context
52-Week High
$5.24
-32.8% from high
52-Week Low
$2.77
+27.1% from low
50-Day SMA
$3.77
-6.6% vs SMA
200-Day SMA
$3.50
+0.6% vs SMA
RSI (14)
47.9
Neutral
Target vs 52W High
$28.90
+451.5% vs high
Next Earnings Report
Nov 11, 2026
3d
until earnings
EPS Est: $-0.23
Earnings in 3 days. Analyst targets may shift significantly after the report.
Peer Consensus — Biotechnology
| Stock | Consensus | Analysts | Buy % | Target | Upside |
|---|---|---|---|---|---|
| ABBV | Strong Buy | 39 | 82% | $257.58 | -11.6% |
| AMGN | Hold | 42 | 43% | $190.87 | -58.5% |
| GILD | Strong Buy | 37 | 81% | $362.68 | +117.3% |
| VRTX | Strong Buy | 39 | 82% | $438.34 | -19.9% |
| MRNA | Hold | 31 | 35% | $149.45 | -41.2% |
| REGN | Buy | 37 | 70% | $76.80 | -91.5% |
| NTRA | Strong Buy | 30 | 90% | $142.91 | -54.0% |
| RVMD | Strong Buy | 29 | 93% | $114.11 | -40.7% |